Three Companies Land Fresh Funds to Advance Pipelines

2021 is shaping up to be another banner year for biotech companies. Funds seem to be in near-endless supply as companies advance the next gen technologies and therapeutics for the health of all. Here’s a few raking in cash for their programs today.